StonvexLoading…
StonvexStonvexStonvexCore line items from KMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.62B | $1.03B | $497.97M | $1.97B |
Operating Income | $169.65M | $90.22M | $37.56M | $143.12M |
Net Income | $115.41M | $57.18M | $23.30M | $93.13M |
EPS (Diluted) | $1.49 | $0.74 | $0.30 | $1.20 |
Total Assets | $2.73B | $2.60B | $2.52B | $2.55B |
Total Liabilities | $1.33B | $1.24B | $1.19B | $1.22B |
Cash & Equivalents | $106.85M | $129.32M | $103.50M | $140.54M |
Free Cash Flow OCF − CapEx | $16.00M | $36.91M | $-5.50M | $119.35M |
Shares Outstanding | 77.23M | 76.92M | 76.83M | 77.89M |